245 related articles for article (PubMed ID: 18779628)
1. Severe acute renal failure following high-dose methotrexate therapy in adults with haematological malignancies: a significant number result from unrecognized co-administration of several drugs.
de Miguel D; García-Suárez J; Martín Y; Gil-Fernández JJ; Burgaleta C
Nephrol Dial Transplant; 2008 Dec; 23(12):3762-6. PubMed ID: 18779628
[No Abstract] [Full Text] [Related]
2. Acute renal failure in a 17-year-old female with ALL receiving escalating intravenous methotrexate without leukovorin.
Kanwar VS; Pearce J
Pediatr Blood Cancer; 2007 Aug; 49(2):216;author reply 219. PubMed ID: 16786587
[No Abstract] [Full Text] [Related]
3. [Managing methotrexate toxicity: a case report].
Fernández Megía MJ; Alós Almiñana M; Terol Castera MJ
Farm Hosp; 2004; 28(5):371-4. PubMed ID: 15504095
[TBL] [Abstract][Full Text] [Related]
4. Pharmacokinetics of methotrexate in cerebrospinal fluid and serum after osmotic blood-brain barrier disruption in patients with brain lymphoma.
Zylber-Katz E; Gomori JM; Schwartz A; Lossos A; Bokstein F; Siegal T
Clin Pharmacol Ther; 2000 Jun; 67(6):631-41. PubMed ID: 10872645
[TBL] [Abstract][Full Text] [Related]
5. Renal failure after high-dose methotrexate in a child homozygous for MTHFR C677T polymorphism.
Turello R; Rentsch K; Di Paolo E; Popovic MB
Pediatr Blood Cancer; 2008 Jan; 50(1):154-6. PubMed ID: 17387702
[TBL] [Abstract][Full Text] [Related]
6. Thymidine rescue: an antidote for pemetrexed-related toxicity in the setting of acute renal failure.
Castro M
J Clin Oncol; 2003 Nov; 21(21):4066. PubMed ID: 14581433
[No Abstract] [Full Text] [Related]
7. [Effect of Chai-ling-tang (Sairei-to) for methotrexate concentration degradation delay by methotrexate high-dose therapy].
Utsuki S; Oka H; Suzuki S; Sato S; Osawa S; Koizumi H; Miyajima Y; Fujii K
No Shinkei Geka; 2010 Feb; 38(2):133-7. PubMed ID: 20166525
[TBL] [Abstract][Full Text] [Related]
8. Transient encephalopathy following high-dose methotrexate.
Lee AC; Li CH; Wong YC
Med Pediatr Oncol; 2003 Jul; 41(1):101. PubMed ID: 12764767
[No Abstract] [Full Text] [Related]
9. Renal dysfunction during and after high-dose methotrexate.
Green MR; Chamberlain MC
Cancer Chemother Pharmacol; 2009 Mar; 63(4):599-604. PubMed ID: 18504579
[TBL] [Abstract][Full Text] [Related]
10. Advances in individual prediction of methotrexate toxicity: a review.
Schmiegelow K
Br J Haematol; 2009 Sep; 146(5):489-503. PubMed ID: 19538530
[TBL] [Abstract][Full Text] [Related]
11. Reversal of neurologic disturbances related to high-dose methotrexate by aminophylline.
Peyriere H; Poiree M; Cociglio M; Margueritte G; Hansel S; Hillaire-Buys D
Med Pediatr Oncol; 2001 Jun; 36(6):662-4. PubMed ID: 11344503
[No Abstract] [Full Text] [Related]
12. [Carboxypeptidase-G2 administration after high-dose methotrexate. Treatment and drug interactions].
Cózar Olmo JA; Martínez Colmenero C; Peláez Pleguezuelos I; Leiva Gea I; López García AB; de la Cruz Moreno J
An Pediatr (Barc); 2009 Sep; 71(3):230-4. PubMed ID: 19617010
[TBL] [Abstract][Full Text] [Related]
13. Anaphylactoid reaction to high-dose methotrexate and re-administration after a successful desensitization.
Caldeira T; Costa V; Silva I; Oliva T; Norton L
Pediatr Hematol Oncol; 2008 Mar; 25(2):131-4. PubMed ID: 18363180
[TBL] [Abstract][Full Text] [Related]
14. [Assessment of elimination and tolerance of high dose of methotrexate (3 g/m2) in children with standard-risk acute lymphoblastic leukemia].
Cwliklińska M; Balwierz W; Nowak J; Stanuch H
Przegl Lek; 2006; 63(1):15-20. PubMed ID: 16892893
[TBL] [Abstract][Full Text] [Related]
15. Rechallenging With Intrathecal Methotrexate After Developing Subacute Neurotoxicity in Children With Hematologic Malignancies.
Badke C; Fleming A; Iqbal A; Khilji O; Parhas S; Weinstein J; Morgan E; Hijiya N
Pediatr Blood Cancer; 2016 Apr; 63(4):723-6. PubMed ID: 26681571
[TBL] [Abstract][Full Text] [Related]
16. Glucarpidase rescue in a patient with high-dose methotrexate-induced nephrotoxicity.
Tuffaha HW; Al Omar S
J Oncol Pharm Pract; 2011 Jun; 17(2):136-40. PubMed ID: 19833686
[TBL] [Abstract][Full Text] [Related]
17. Acral erythema with oral methotrexate in a child.
Varela CR; McNamara J; Antaya RJ
Pediatr Dermatol; 2007; 24(5):541-6. PubMed ID: 17958806
[TBL] [Abstract][Full Text] [Related]
18. Extremely slow methotrexate elimination in a patient with t(9;22) positive acute lymphoblastic leukemia treated with imatinib.
Van Hest RM; Schnog JB; Van't Veer MB; Cornelissen JJ
Am J Hematol; 2008 Sep; 83(9):757-8. PubMed ID: 18615671
[No Abstract] [Full Text] [Related]
19. Intrathecal methotrexate-induced acute cerebellar syndrome.
Ferhanoglu B; Ongören S; Ar CM; Uzel B; Forta H; Necioglu D
Ann Hematol; 2003 Apr; 82(4):241-3. PubMed ID: 12707728
[TBL] [Abstract][Full Text] [Related]
20. [Management recommendations in patients with methotrexate intoxication].
Schellens JH; Beijnen JH
Ned Tijdschr Geneeskd; 2007 Feb; 151(6):337-41. PubMed ID: 17352296
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]